U.S. Packaging Stock News

Spire Global (SPIR) recently became profitable, with its net profit margin turning positive over the past year. Despite crossing into the black, earnings are forecast to decline sharply at an annual rate of 70% over the next three years, even as revenue is projected to grow just 2.5% per year, lagging far behind the US market average of 10.5%. For investors, this means the company is coming off a milestone of positive earnings, but expectations remain muted due to forecasts for falling...

Core Molding Technologies (CMT) is aiming for a massive 46.5% annual EPS growth rate over the next three years, which easily outpaces the US market average of 16%. This outlook comes as the company posts a forecasted 6.4% revenue growth per year, lagging the US market’s 10.5% average, and a net profit margin of 3.1%, down from 4.9% a year ago. After growing earnings at 20.7% per year over the last five years, CMT enters this period with a high-quality earnings track record but faces margin...

Vishay Precision Group (VPG) reported a net profit margin of 2.7%, dropping from last year’s 4.2%. Over the past five years, the company’s earnings have declined by 7.6% each year, with the latest period benefiting from a one-off $4.4 million gain as of September 27, 2025. However, with earnings expected to rise 54.7% per year going forward, investors are weighing persistent pressure on margins against forecasts that point to a significant rebound. See our full analysis for Vishay Precision...

Taysha Gene Therapies (TSHA) remains unprofitable, but its revenue is forecast to grow rapidly by 70.5% per year, far outpacing the broader US market's expected 10.5% annual growth. Over the past five years, the company has managed to cut its losses at a 7.5% annual rate, even as it is projected to stay in the red for at least the next three years. With shares recently trading at $4.27, below an estimated fair value of $20.71, investors are weighing the promise of significant top-line growth...

Portillo’s (PTLO) is forecast to grow revenue at 8.5% per year, which trails the broader US market’s pace of 10.5%. Despite this, the company’s earnings are expected to climb 16.9% per year, a notch above the market’s 16% average, while net profit margins edged down to 3.4% from last year’s 3.6%. Investors are watching this mix of slower sales growth but faster earnings momentum, especially as the company maintains modest profitability and a valuation that sits between direct peers and the...

Park National (PRK) posted robust earnings momentum, with profit rising by 28.2% in the most recent period. This marks a significant jump over the company’s steady 2.3% annual earnings growth rate over the past five years. Net profit margins expanded to 32.9% from last year’s 28.3%, giving investors a tangible boost in efficiency and profitability. With forecasts pointing to 5.6% annual earnings growth and a revenue growth outlook of 10.5% per year, Park National’s results position it as a...

Leidos Holdings (LDOS) posted 16.9% earnings growth for the past year, outpacing its five-year average of 13.7% per year. Net profit margin also improved to 8.1% from last year’s 7.4%, while management continues to deliver high-quality results. Looking ahead, consensus expects earnings to increase by 3.5% per year and revenue by 2.7%, both trailing the broader U.S. market averages. See our full analysis for Leidos Holdings. Next, we will see how these headline numbers compare to the current...

TPG (TPG) delivered standout earnings, with net profit margins improving dramatically to 2.3% from 0.3% a year ago and earnings for the past year surging 997.3%, a big reversal from the five-year average decline of 81.6% per year. While earnings are forecast to grow at a rapid 49% per year over the next three years, well ahead of the broader US market’s 16% pace, revenue is expected to decline by 13.4% annually, highlighting a disconnect between bottom- and top-line trends. With shares...

Castle Biosciences (CSTL) continues to operate at a loss, with recent filings confirming the company has yet to achieve net profit margin improvement over the past year and is still generating negative earnings. Despite reducing its annual losses at a rate of 9.6% per year over the last five years, it remains on a slower growth path. Forecasted revenue is expected to rise 6.5% per year, lagging behind the broader US market’s 10.5% annual growth rate. With profitability still out of reach in...

LGI Homes (LGIH) reported a 20.4% annual decline in earnings over the past five years, with current net profit margins at 5.9% compared to 8.8% previously. However, revenue is projected to grow at 17.4% per year, while EPS is expected to jump by 27.4% annually for the next three years, outpacing the broader US market’s 16% outlook. With margins under recent pressure but robust growth prospects ahead, investors will be weighing risks from declining profitability against strong forward-looking...

Marzetti (MZTI) delivered a steady financial performance, with profits climbing at a 6.5% annual rate on the back of a 6.3% compound annual growth rate over five years. Net profit margins edged up to 8.7% from last year’s 8.5%, and revenue is projected to grow at a restrained 1.5% per year compared to the broader US market’s 10.5% pace. Earnings per share are expected to rise by about 8% annually, undershooting the US market average of 16%, while the current share price of $173.21 stands well...

Rhythm Pharmaceuticals (RYTM) reported widening losses, with net losses having grown at a rate of 18.8% per year over the past five years. Despite being unprofitable, the company commands a Price-To-Sales Ratio of 40x, outpacing both the US Biotechs industry average of 10.8x and the peer average of 17.9x, positioning its stock as highly valued on these multiples. On the growth front, forecasts point to revenue expanding at 45.8% per year and earnings projected to grow 70.56% per year, with...

PRA Group (PRAA) is currently unprofitable, with losses having grown at an average annual rate of 48.8% over the last five years. While revenue is projected to grow at 6.6% per year, this is slower than the broader US market’s pace of 10.5% per year. The company is expected to remain unprofitable for at least the next three years. Margins have seen no improvement over the past year, signaling that profitability remains a persistent challenge for investors considering this stock. See our full...

Ormat Technologies (ORA) posted net profit margins of 14.1%, up from last year’s 13.3%, and delivered 16.7% average annual earnings growth over the past five years. However, the latest year’s earnings growth was 12.4%, trailing both the company’s own historical average and the projected pace of 8.1% earnings and 8.6% revenue growth going forward. Both figures are below the US market’s forecasted profit and revenue growth rates of 16% and 10.5%. These results come as the stock trades at a...

BWX Technologies (NYSE:BWXT) is expected to deliver annual earnings growth of 10.8% and revenue growth of 8.7%. These rates trail the broader US market averages of 16% and 10.5%, respectively. Net profit margins sit at 10%, marking a slight dip from last year’s 10.3%. Notably, the company’s earnings have jumped 10.9% over the past year compared to a five-year average of just 0.2% per year. With the stock trading well above the fair value estimate and at a price-to-earnings ratio higher than...

Apple Hospitality REIT (APLE) delivered mixed results in its latest earnings, with a notable reversal in momentum from previous years. Net profit margins declined to 12.4% compared to last year’s 14.5%, and the company posted negative earnings growth over the past twelve months after growing earnings by 49.5% annually over the last five years. Looking ahead, management expects revenue to rise just 1.8% per year and earnings to grow at 0.7%, both lagging the broader US market. This may weigh...

Douglas Dynamics (PLOW) posted a net profit margin of 6.6%, down from 9.7% last year, ending a five-year run of strong profitability gains that saw average annual earnings growth of 45.8%. Revenue is projected to rise by 6.5% annually, trailing the broader US market's 10.5% pace. Expected EPS growth of 14.7% also lags behind the 16% market forecast. Investors are likely to view these results as a sign of recent margin pressure. However, with shares trading below fair value and analyst...

Becton Dickinson (BDX) just announced major milestones across its diagnostics and medical device segments, including regulatory wins for its new enteric bacterial panels and the full enrollment of a key patient cohort in its AGILITY vascular stent study. See our latest analysis for Becton Dickinson. While these clinical and regulatory developments underscore Becton Dickinson’s momentum in diagnostics and medical devices, the company’s recent share price return tells a different story. Despite...

Eastman Chemical (EMN) reported a net profit margin of 7.7%, down from last year’s 9.5%, with a five-year annualized earnings growth rate of 9.2%. Shares are trading at $60.74, well below the estimated fair value of $152.01 by discounted cash flow analysis. Expectations are for earnings to grow by 10.88% per year, which is slower than both the broader US market's 16% pace and the threshold for significant growth. Investors see good value here due to low price-to-earnings ratios and high...

Phillips 66 (NYSE:PSX) just hit its highest refining utilization since 2018, thanks to streamlined operations and a fresh acquisition in its refinery portfolio. The company has also recently accelerated share repurchases, highlighting shareholder returns. See our latest analysis for Phillips 66. Despite some choppy quarters, Phillips 66 has seen momentum pick up, with its 90-day share price return climbing 13.3% and a year-to-date price gain of 18.7%. Recent events such as its sizable share...

PotlatchDeltic (PCH) delivered a sharp turnaround in profitability this quarter, with its net profit margin climbing to 5.8%, up from just 1.6% a year ago, and earnings rising 288.4% year-over-year. This is far stronger than its five-year average, which saw earnings declining 38.9% per year. Looking ahead, the company is forecasting annual earnings growth of 17.9%, set to outpace the broader US market, while management values shares below their estimated fair value at $38.95. These improving...

Unitil (UTL) reported earnings that have grown at an average rate of 8.3% per year over the last five years. However, its most recent year saw a negative earnings result, making a direct comparison to its longer-term trend difficult. Revenue is projected to rise 5.1% annually, which is notably slower than the broader US market’s anticipated 10.5% pace. The company’s net profit margin slipped to 9.3% from 9.5% last year. Despite the recent softness, Unitil’s high-quality earnings and a share...

Wondering whether FactSet Research Systems is a smart buy at current levels? You are not alone in asking if now is the time to take a closer look at its value. The stock has seen some notable movement lately, dropping 8.3% over the past week and down 44.5% year-to-date, suggesting shifting market sentiment that could spell opportunity or signal new risks. Recent news in the data and analytics sector, including growing competition and evolving client needs, has prompted investors to reassess...

American Tower (AMT) caught attention after releasing its third-quarter results, which showed a clear uptick in sales and net income. The company also raised its 2025 earnings outlook, reflecting management’s confidence in the face of ongoing industry challenges. See our latest analysis for American Tower. While American Tower’s revenue and net income have climbed, the broader story for investors is more nuanced. Despite the upbeat earnings and a fresh round of share buybacks, the company’s...